FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli
- Details
- Category: FDA
The U.S. Food and Drug Administration advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli.
FDA Announces Collaboration with Drugs.com
- Details
- Category: FDA
The U.S. Food and Drug Administration announced today that it will collaborate with the Web site Drugs.com to expand access to the FDA's consumer health information. Drugs.com seeks to provide patients with information to better manage their own health care and to assist in the reduction of medication errors.
'Bad Ad Program' to Help Health Care Providers Detect, Report Misleading Drug Ads
- Details
- Category: FDA
The U.S. Food and Drug Administration launched a program designed to educate health care providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
FDA Requests $4.03 Billion to Promote and Protect Public Health
- Details
- Category: FDA
The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the Presidentâs fiscal year 2011 budget - a 23 percent increase over the agencyâs current $3.28 billion budget.
FDA Commissioner Addresses Nation's Healthcare Professionals on H1N1 Vaccine
- Details
- Category: FDA
Dr. Margaret Hamburg, Commissioner of Food and Drugs, sent a letter to America's healthcare professionals thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on the safety of the 2009 H1N1 vaccines.
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet
- Details
- Category: FDA
The U.S. Food and Drug Administration warns consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients.
European Medicines Agency implements internal reorganisation
- Details
- Category: EMA
The European Medicines Agency has begun implementing a series of changes to its internal organisation aimed at improving the functioning of the Agency and the way in which it delivers its core tasks. The changes will be introduced gradually from September to December 2009.
More Pharma News ...
- FDA Marks 100th HIV/AIDS Drug Authorized for Purchase Under PEPFAR
- The bacterial challenge - time to react
- FDA: Cancer Warnings Required for TNF Blockers
- European Medicines Agency review of pandemic vaccines underway
- FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene
- European public health agencies evaluate antibiotic resistance of Staphylococcus aureus
- European Medicines Agency recommendations on extension of shelf life for Tamiflu